148 related articles for article (PubMed ID: 8347960)
1. Three-dimensional MR imaging and display of intracranial disease: improvements with the MP-RAGE sequence and gadolinium.
Brant-Zawadzki MN; Gillan GD; Atkinson DJ; Edalatpour N; Jensen M
J Magn Reson Imaging; 1993; 3(4):656-62. PubMed ID: 8347960
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging of the brain with gadopentetate dimeglumine-DTPA: comparison of T1-weighted spin-echo and 3D gradient-echo sequences.
Li D; Haacke EM; Tarr RW; Venkatesan R; Lin W; Wielopolski P
J Magn Reson Imaging; 1996; 6(3):415-24. PubMed ID: 8724406
[TBL] [Abstract][Full Text] [Related]
3. MP-RAGE subtraction venography: a new technique.
Stevenson J; Knopp EA; Litt AW
J Magn Reson Imaging; 1995; 5(2):239-41. PubMed ID: 7766987
[TBL] [Abstract][Full Text] [Related]
4. Theoretical analysis of gadopentetate dimeglumine enhancement in T1-weighted imaging of the brain: comparison of two-dimensional spin-echo and three-dimensional gradient-echo sequences.
Mugler JP; Brookeman JR
J Magn Reson Imaging; 1993; 3(5):761-9. PubMed ID: 8400563
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced MR imaging of metastatic brain tumor at 3 tesla: utility of T(1)-weighted SPACE compared with 2D spin echo and 3D gradient echo sequence.
Komada T; Naganawa S; Ogawa H; Matsushima M; Kubota S; Kawai H; Fukatsu H; Ikeda M; Kawamura M; Sakurai Y; Maruyama K
Magn Reson Med Sci; 2008; 7(1):13-21. PubMed ID: 18460844
[TBL] [Abstract][Full Text] [Related]
6. Optimizing brain MR imaging protocols with gadopentetate dimeglumine: enhancement of intracranial lesions on spin-density- and T2-weighted images.
Wessbecher FW; Maravilla KR; Dalley RW
AJNR Am J Neuroradiol; 1991; 12(4):675-9. PubMed ID: 1882743
[TBL] [Abstract][Full Text] [Related]
7. Intracranial lesion enhancement with gadolinium: T1-weighted spin-echo versus three-dimensional Fourier transform gradient-echo MR imaging.
Mirowitz SA
Radiology; 1992 Nov; 185(2):529-34. PubMed ID: 1410367
[TBL] [Abstract][Full Text] [Related]
8. MR imaging of the brain in patients with AIDS: value of routine use of i.v. gadopentetate dimeglumine.
Jensen MC; Brant-Zawadzki M
AJR Am J Roentgenol; 1993 Jan; 160(1):153-7. PubMed ID: 8416615
[TBL] [Abstract][Full Text] [Related]
9. Gd-DTPA-enhanced 3D MR imaging of cervical degenerative disk disease: initial experience.
Ross JS; Ruggieri PM; Tkach JA; Masaryk TJ; Paranandi L; Dillinger JJ; Modic MT
AJNR Am J Neuroradiol; 1992; 13(1):127-36. PubMed ID: 1595430
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional, T1-weighted gradient-echo imaging of the brain with a volumetric interpolated examination.
Wetzel SG; Johnson G; Tan AG; Cha S; Knopp EA; Lee VS; Thomasson D; Rofsky NM
AJNR Am J Neuroradiol; 2002; 23(6):995-1002. PubMed ID: 12063232
[TBL] [Abstract][Full Text] [Related]
11. Gadolinium-enhanced three-dimensional magnetization-prepared rapid gradient-echo (3D MP-RAGE) imaging is superior to spin-echo imaging in delineating brain metastases.
Takeda T; Takeda A; Nagaoka T; Kunieda E; Takemasa K; Watanabe M; Hatou T; Oguro S; Katayama M
Acta Radiol; 2008 Dec; 49(10):1167-73. PubMed ID: 18979271
[TBL] [Abstract][Full Text] [Related]
12. Postoperative evaluation for intracranial recurrence of medulloblastoma: MR findings with gadopentetate dimeglumine.
Meyers SP; Wildenhain S; Chess MA; Tarr RW
AJNR Am J Neuroradiol; 1994 Sep; 15(8):1425-34. PubMed ID: 7985559
[TBL] [Abstract][Full Text] [Related]
13. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
[TBL] [Abstract][Full Text] [Related]
14. A comparison of magnetization prepared 3D gradient-echo (MP-RAGE) sequences for imaging of intracranial lesions.
Blüml S; Schad LR; Scharf J; Wenz F; Knopp MV; Lorenz WJ
Magn Reson Imaging; 1996; 14(3):329-35. PubMed ID: 8725198
[TBL] [Abstract][Full Text] [Related]
15. MR of intracranial tumors: combined use of gadolinium and magnetization transfer.
Kurki T; Niemi P; Valtonen S
AJNR Am J Neuroradiol; 1994 Oct; 15(9):1727-36. PubMed ID: 7847221
[TBL] [Abstract][Full Text] [Related]
16. Reverse enhancement of hemorrhagic brain lesions on postcontrast MR: detection with digital image subtraction.
Gaul HP; Wallace CJ; Crawley AP
AJNR Am J Neuroradiol; 1996 Oct; 17(9):1675-80. PubMed ID: 8896621
[TBL] [Abstract][Full Text] [Related]
17. Segmentation and visualization of brain lesions in multispectral magnetic resonance images.
Holden M; Steen E; Lundervold A
Comput Med Imaging Graph; 1995; 19(2):171-83. PubMed ID: 7780944
[TBL] [Abstract][Full Text] [Related]
18. Use of MR imaging contrast agents in the brain.
Bradley WG; Yuh WT; Bydder GM
J Magn Reson Imaging; 1993; 3(1):199-218. PubMed ID: 8428088
[No Abstract] [Full Text] [Related]
19. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
Jung HW; Chang KH; Choi DS; Han MH; Han MC
AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
[TBL] [Abstract][Full Text] [Related]
20. Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment.
Mihara F; Gupta KL; Righi AM
Radiat Med; 1994; 12(5):209-12. PubMed ID: 7863024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
